Literature DB >> 21697078

Disrupted fat distribution and composition due to medium-chain triglycerides in mice with a β-oxidation defect.

Sara Tucci1, Ulrich Flögel, Marga Sturm, Elena Borsch, Ute Spiekerkoetter.   

Abstract

BACKGROUND: Because of the enhanced recognition of inherited long-chain fatty acid oxidation disorders by worldwide newborn screening programs, an increasing number of asymptomatic patients receive medium-chain triglyceride (MCT) supplements to prevent the development of cardiomyopathy and myopathy.
OBJECTIVE: MCT supplementation has been recognized as a safe dietary intervention, but long-term observations into later adulthood are still not available. We investigated the consequences of a prolonged MCT diet on abdominal fat distribution and composition and on liver fat.
DESIGN: Mice with very-long-chain acyl-coenzyme A dehydrogenase deficiency (VLCAD(-/-)) were supplemented for 1 y with a diet in which MCTs replaced long-chain triglycerides without increasing the total fat content. The dietary effects on abdominal fat accumulation and composition were analyzed by in vivo (1)H- and (13)C-magnetic resonance spectroscopy (9.4 Tesla).
RESULTS: After 1 y of MCT supplementation, VLCAD(-/-) mice accumulated massive visceral fat and had a dramatic increase in the concentration of serum free fatty acids. Furthermore, we observed a profound shift in body triglyceride composition, ie, concentrations of physiologically important polyunsaturated fatty acids dramatically decreased. (1)H-Magnetic resonance spectroscopy analysis and histologic evaluation of the liver also showed pronounced fat accumulation and marked oxidative stress.
CONCLUSION: Although the MCT-supplemented diet has been reported to prevent the development of cardiomyopathy and skeletal myopathy in fatty acid oxidation disorders, our data show that long-term MCT supplementation results in a severe clinical phenotype similar to that of nonalcoholic steatohepatitis and the metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21697078     DOI: 10.3945/ajcn.111.012948

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  14 in total

Review 1.  Cell and gene therapy for genetic diseases: inherited disorders affecting the lung and those mimicking sudden infant death syndrome.

Authors:  Allison M Keeler; Terence R Flotte
Journal:  Hum Gene Ther       Date:  2012-06       Impact factor: 5.695

2.  Clinical practice and the development of evidence.

Authors:  Bridget Wilcken
Journal:  J Inherit Metab Dis       Date:  2012-01       Impact factor: 4.982

3.  Triheptanoin: long-term effects in the very long-chain acyl-CoA dehydrogenase-deficient mouse.

Authors:  Sara Tucci; Ulrich Floegel; Frauke Beermann; Sidney Behringer; Ute Spiekerkoetter
Journal:  J Lipid Res       Date:  2016-11-24       Impact factor: 5.922

Review 4.  Very long-chain acyl-CoA dehydrogenase (VLCAD-) deficiency-studies on treatment effects and long-term outcomes in mouse models.

Authors:  Sara Tucci
Journal:  J Inherit Metab Dis       Date:  2017-02-28       Impact factor: 4.982

5.  Triheptanoin treatment in patients with pediatric cardiomyopathy associated with long chain-fatty acid oxidation disorders.

Authors:  J Vockley; J Charrow; J Ganesh; M Eswara; G A Diaz; E McCracken; R Conway; G M Enns; J Starr; R Wang; J E Abdenur; J Sanchez-de-Toledo; D L Marsden
Journal:  Mol Genet Metab       Date:  2016-08-27       Impact factor: 4.797

6.  Successful Treatment of Cardiomyopathy due to Very Long-Chain Acyl-CoA Dehydrogenase Deficiency: First Case Report from Oman with Literature Review.

Authors:  Sharef Waadallah Sharef; Khalfan Al-Senaidi; Surendra Nath Joshi
Journal:  Oman Med J       Date:  2013-09

7.  Cinnamomum camphora Seed Kernel Oil Improves Lipid Metabolism and Enhances β3-Adrenergic Receptor Expression in Diet-Induced Obese Rats.

Authors:  Jing Fu; Cheng Zeng; Zheling Zeng; Baogui Wang; Xuefang Wen; Ping Yu; Deming Gong
Journal:  Lipids       Date:  2016-04-11       Impact factor: 1.880

8.  Tissue-specific strategies of the very-long chain acyl-CoA dehydrogenase-deficient (VLCAD-/-) mouse to compensate a defective fatty acid β-oxidation.

Authors:  Sara Tucci; Diran Herebian; Marga Sturm; Annette Seibt; Ute Spiekerkoetter
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

9.  Long-term correction of very long-chain acyl-coA dehydrogenase deficiency in mice using AAV9 gene therapy.

Authors:  Allison M Keeler; Thomas Conlon; Glenn Walter; Huadong Zeng; Scott A Shaffer; Fu Dungtao; Kirsten Erger; Travis Cossette; Qiushi Tang; Christian Mueller; Terence R Flotte
Journal:  Mol Ther       Date:  2012-03-06       Impact factor: 11.454

Review 10.  The role of metabolic syndrome in sudden cardiac death risk: Recent evidence and future directions.

Authors:  Amedeo Tirandi; Federico Carbone; Fabrizio Montecucco; Luca Liberale
Journal:  Eur J Clin Invest       Date:  2021-11-08       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.